The Pain Clinic Monitor tracks prescriptions and treatments, as well as detailing in this key ‘point of care prescribing segment’ of the Pain Market – Pain Clinics. This segment represents high levels of prescribing intensity and new prescription initiation.

Today there are more than 2,000 free standing and university based clinics in the U.S., up from just 500 in 1998.

Sign up for the year, and you will obtain MONTHLY input, including access to the following:

» 5,000 patients in Q1 & Q2, expecting 10,000 for 2008
» 27 Pain Condition Profiles
» Drugs prescribed (up to 7 per patient)
» Drugs administered in the office
» Drugs discontinued, and why
» 1,800+ Drug Detail Visits

Methodology: Monthly web-based survey of custom-built panel of 100 pre-screened pain clinics recruited from more than 2,000 pre-identified pain clinics. Representative of the entire population of pain clinics, as reported in a recent study profiling pain clinics, published in the Journal of Pain in 2007.

With this monitor you will be able to:

» Track in-office treatments and prescribed drugs
» Track detailing by company, product and message
» Assess the potential for new product opportunities
» Gain an understanding of the complete set of drugs prescribed for a given pain condition
» More effectively target you company’s Marketing, Promotional and Professional Education activities

This 4th edition of our well-received report on Neuropathic Pain draws upon WWMR’s Pain Clinic Monitor, for NEW details on treatment and office-visit frequency. As always, the report provides expert analysis and commentary on the future Neuropathic Pain market.

Epi-based projections of patient populations, and prescription-based estimates of the commercial value (USD) of this market in 2008, 2013, and 2018 are provided. These models incorporate the important features of key conditions associated with Neuropathic Pain:

» Neuropathic back pain
» Diabetic neuropathic
» Complex regional pain syndrome
» HIV/AIDS neuropathy
» Post-herpetic neuralgia
» Phantom limb pain
» Spinal cord injury
» Trigeminal neuralgia

Plus 2 NEW indications in 2008

» Fibromyalgia
» Neuropathic cancer pain

The 2nd Edition of the European Neuropathic Pain report provides an assessment for the major conditions causing neuropathic pain in the five major European pharmaceutical markets.

This 1st Edition of the Japanese Neuropathic Pain report will provide the same high-quality assessment for the major conditions causing neuropathic pain as has been found in our US and European Editions.